Raulet Lab
David Raulet
Immunotherapy of Cancer via Mobilization of NK Cells, NK Cell Inhibition by KIR/Ly49 and Checkpoint Receptors, NK Cell Tolerance and Desensitization to MHC I-deficient Cells, NK Cell Desensitization to Normal Cells Expressing NKG2D Ligands, Analysis of Autochthonous Tumor Models
Learn more